Using an artificial-intelligence-based algorithm, the expression of these genes was also investigated in a large dataset of CTCL patients, demonstrating that the most predictor of CTCL early stage was FOXP3, the principal transcription factor for the Treg T-cell phenotype. Here, FOXP3 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.